snf472
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started May 1, 2016 (NCT02790073)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- snf472
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04195906 | Phase 3 | Feb 29, 2020 | Sanifit |
| NCT02966028 | Phase 2 | Nov 1, 2016 | Clinipace LTD, Sanifit |
| NCT02790073 | Phase 2 | May 1, 2016 | RWTH Aachen University, Sanifit |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sanifit | For profit | 3 | 3 | 2 | 2016 |
| Clinipace LTD | For profit | 1 | 0 | 1 | 2016 |
| RWTH Aachen University | Academic/Hospital | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1